Literature DB >> 26368650

Neurogranin Levels in Cerebrospinal Fluid: A New Addition to the Alzheimer Disease Diagnostic Toolbox.

Henrik Zetterberg1, Kaj Blennow2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26368650     DOI: 10.1001/jamaneurol.2015.2075

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


× No keyword cloud information.
  8 in total

Review 1.  Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.

Authors:  Piotr Lewczuk; Peter Riederer; Sid E O'Bryant; Marcel M Verbeek; Bruno Dubois; Pieter Jelle Visser; Kurt A Jellinger; Sebastiaan Engelborghs; Alfredo Ramirez; Lucilla Parnetti; Clifford R Jack; Charlotte E Teunissen; Harald Hampel; Alberto Lleó; Frank Jessen; Lidia Glodzik; Mony J de Leon; Anne M Fagan; José Luis Molinuevo; Willemijn J Jansen; Bengt Winblad; Leslie M Shaw; Ulf Andreasson; Markus Otto; Brit Mollenhauer; Jens Wiltfang; Martin R Turner; Inga Zerr; Ron Handels; Alexander G Thompson; Gunilla Johansson; Natalia Ermann; John Q Trojanowski; Ilker Karaca; Holger Wagner; Patrick Oeckl; Linda van Waalwijk van Doorn; Maria Bjerke; Dimitrios Kapogiannis; H Bea Kuiperij; Lucia Farotti; Yi Li; Brian A Gordon; Stéphane Epelbaum; Stephanie J B Vos; Catharina J M Klijn; William E Van Nostrand; Carolina Minguillon; Matthias Schmitz; Carla Gallo; Andrea Lopez Mato; Florence Thibaut; Simone Lista; Daniel Alcolea; Henrik Zetterberg; Kaj Blennow; Johannes Kornhuber
Journal:  World J Biol Psychiatry       Date:  2017-10-27       Impact factor: 4.132

2.  Neurogranin, a synaptic protein, is associated with memory independent of Alzheimer biomarkers.

Authors:  Kaitlin B Casaletto; Fanny M Elahi; Brianne M Bettcher; John Neuhaus; Barbara B Bendlin; Sanjay Asthana; Sterling C Johnson; Kristine Yaffe; Cynthia Carlsson; Kaj Blennow; Henrik Zetterberg; Joel H Kramer
Journal:  Neurology       Date:  2017-09-22       Impact factor: 9.910

3.  A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease.

Authors:  Susanne Ostrowitzki; Robert A Lasser; Ernest Dorflinger; Philip Scheltens; Frederik Barkhof; Tania Nikolcheva; Elizabeth Ashford; Sylvie Retout; Carsten Hofmann; Paul Delmar; Gregory Klein; Mirjana Andjelkovic; Bruno Dubois; Mercè Boada; Kaj Blennow; Luca Santarelli; Paulo Fontoura
Journal:  Alzheimers Res Ther       Date:  2017-12-08       Impact factor: 6.982

4.  Intrahippocampal injection of a lentiviral vector expressing neurogranin enhances cognitive function in 5XFAD mice.

Authors:  Seong Gak Jeon; Moonkyung Kang; Yeon-Soo Kim; Dong-Hyun Kim; Dong Woo Nam; Eun Ji Song; Inhee Mook-Jung; Minho Moon
Journal:  Exp Mol Med       Date:  2018-03-23       Impact factor: 8.718

5.  CSF synaptic protein concentrations are raised in those with atypical Alzheimer's disease but not frontotemporal dementia.

Authors:  Mica T M Clarke; Ann Brinkmalm; Martha S Foiani; Ione O C Woollacott; Carolin Heller; Amanda Heslegrave; Ashvini Keshavan; Nick C Fox; Jonathan M Schott; Jason D Warren; Kaj Blennow; Henrik Zetterberg; Jonathan D Rohrer
Journal:  Alzheimers Res Ther       Date:  2019-12-17       Impact factor: 6.982

Review 6.  Advances in the development of new biomarkers for Alzheimer's disease.

Authors:  Timofey O Klyucherev; Pawel Olszewski; Alena A Shalimova; Vladimir N Chubarev; Vadim V Tarasov; Misty M Attwood; Stina Syvänen; Helgi B Schiöth
Journal:  Transl Neurodegener       Date:  2022-04-21       Impact factor: 9.883

7.  Sulforaphane Upregulates Cultured Mouse Astrocytic Aquaporin-4 Expression through p38 MAPK Pathway.

Authors:  Canhong Yang; Sisi Qin; Jiafa Zhang; Yuanyuan Wang; Huan Li; Tianming Lü
Journal:  J Healthc Eng       Date:  2022-08-10       Impact factor: 3.822

8.  Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modification.

Authors:  Nicholas J Izzo; Carla M Yuede; Kelsie M LaBarbera; Colleen S Limegrover; Courtney Rehak; Raymond Yurko; Lora Waybright; Gary Look; Gilbert Rishton; Hank Safferstein; Mary E Hamby; Claire Williams; Kelsey Sadlek; Hannah M Edwards; Charles S Davis; Michael Grundman; Lon S Schneider; Steven T DeKosky; Daniel Chelsky; Ian Pike; Christopher Henstridge; Kaj Blennow; Henrik Zetterberg; Harry LeVine; Tara L Spires-Jones; John R Cirrito; Susan M Catalano
Journal:  Alzheimers Dement       Date:  2021-02-08       Impact factor: 21.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.